TOP > 外国特許検索 > ANTI-HEPATOMA-VIRUS AGENT

ANTI-HEPATOMA-VIRUS AGENT UPDATE

外国特許コード F170009243
整理番号 (S2016-0463-N0)
掲載日 2017年9月21日
出願国 世界知的所有権機関(WIPO)
国際出願番号 2017JP009674
国際公開番号 WO 2017155082
国際出願日 平成29年3月10日(2017.3.10)
国際公開日 平成29年9月14日(2017.9.14)
優先権データ
  • 特願2016-048664 (2016.3.11) JP
発明の名称 (英語) ANTI-HEPATOMA-VIRUS AGENT UPDATE
発明の概要(英語) The purpose of the present invention is to provide a novel therapeutic agent against hepatoma viruses. Specifically, the present invention pertains to an anti-hepatoma-virus agent containing, as an active ingredient, a compound represented by general formula (I): (in the formula, R1 is fluorine or hydrogen) or a pharmacologically acceptable salt thereof.
特許請求の範囲(英語) [claim1]
1. General formula (i) below:
[Conversion 1]
(In formula, R [1] is fluorine or hydrogen)
So the chemical compound which is shown or it contains the salt which that pharmacy is allowed, as the active ingredient the anti- liver tumor virus medicine.
[claim2]
2. The chemical compound which is shown with general formula (i) or the salt which that pharmacy is allowed 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or is the salt which that pharmacy is allowed, at the same time the liver tumor virus the B type hepatitis virus and/or is C type hepatitis virus, the anti- liver tumor virus medicine of claim 1 statement.
[claim3]
3. The chemical compound which is shown with general formula (i) or the salt which that pharmacy is allowed 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or is the salt which that pharmacy is allowed, at the same time the liver tumor virus is the B type hepatitis virus or C type hepatitis virus, the anti- liver tumor virus medicine of claim 1 statement.
[claim4]
4. The chemical compound which is shown with general formula (i) or the salt which that pharmacy is allowed 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or is the salt which that pharmacy is allowed, at the same time the liver tumor virus is the B type hepatitis virus, the anti- liver tumor virus medicine of claim 1 statement.
[claim5]
5. The chemical compound which is shown with general formula (i) or the salt which that pharmacy is allowed 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or is the salt which that pharmacy is allowed, at the same time the liver tumor virus is C type hepatitis virus, the anti- liver tumor virus medicine of claim 1 statement.
[claim6]
6. The chemical compound which is shown with general formula (i) or the salt which that pharmacy is allowed 2 - kuroro - 9- (2 - deoxy - .beta.-D-arabinohuranoshiru) adenine or is the salt which that pharmacy is allowed, at the same time the liver tumor virus is C type hepatitis virus, the anti- liver tumor virus medicine of claim 1 statement.
[claim7]
7. Being liver tumor virus-related diseased prevention or the remedy medicine which contains the anti- liver tumor virus medicine of claim 1 statement, the aforementioned-related disease the chronic hepatitis, is selected from the group which consists of the hepatic cirrhosis and the liver cancer, the aforementioned prevention or the remedy medicine.
[claim8]
8. 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or the anti- liver tumor virus medicine which is the salt which that pharmacy is allowed is contained, at the same time the liver tumor virus-related disease the B type hepatitis virus and/or is C type hepatitis virus-related disease, the preventive of claim 7 statement or remedy medicine.
[claim9]
9. 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or the anti- liver tumor virus medicine which is the salt which that pharmacy is allowed is contained, at the same time the liver tumor virus-related disease is the B type hepatitis virus or C type hepatitis virus-related disease, the preventive of claim 7 statement or remedy medicine.
[claim10]
10. 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or the anti- liver tumor virus medicine which is the salt which that pharmacy is allowed is contained, at the same time the liver tumor virus-related disease is the B type hepatitis virus-related disease, the preventive of claim 7 statement or remedy medicine.
[claim11]
11. 2 - kuroro - 9- (2 - deoxy - 2 - fluoro - .beta.-D-arabinohuranoshiru) adenine or the anti- liver tumor virus medicine which is the salt which that pharmacy is allowed is contained, at the same time the liver tumor virus-related disease is C type hepatitis virus-related disease, the preventive of claim 7 statement or remedy medicine.
[claim12]
12. 2 - kuroro - 9- (2 - deoxy - .beta.-D-arabinohuranoshiru) adenine or the anti- liver tumor virus medicine which is the salt which that pharmacy is allowed is contained, at the same time the liver tumor virus-related disease is C type hepatitis virus-related disease, the preventive of claim 7 statement or remedy medicine.
  • 出願人(英語)
  • ※2012年7月以前掲載分については米国以外のすべての指定国
  • KAGOSHIMA UNIVERSITY
  • OKAYAMA UNIVERSITY
  • DAIKIN INDUSTRIES, LTD.
  • 発明者(英語)
  • IKEDA MASANORI
  • TAKEDA MIDORI
  • BABA MASANORI
  • KATO NOBUYUKI
国際特許分類(IPC)
指定国 (WO2017155082)
National States: AE AG AL AM AO AT AU AZ BA BB BG BH BN BR BW BY BZ CA CH CL CN CO CR CU CZ DE DJ DK DM DO DZ EC EE EG ES FI GB GD GE GH GM GT HN HR HU ID IL IN IR IS JP KE KG KH KN KP KR KW KZ LA LC LK LR LS LU LY MA MD ME MG MK MN MW MX MY MZ NA NG NI NO NZ OM PA PE PG PH PL PT QA RO RS RU RW SA SC SD SE SG SK SL SM ST SV SY TH TJ TM TN TR TT TZ UA UG US UZ VC VN ZA ZM ZW
ARIPO: BW GH GM KE LR LS MW MZ NA RW SD SL SZ TZ UG ZM ZW
EAPO: AM AZ BY KG KZ RU TJ TM
EPO: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
OAPI: BF BJ CF CG CI CM GA GN GQ GW KM ML MR NE SN ST TD TG
特許の内容に興味を持たれた方、ライセンスをご希望の方は、下記「問合せ先」までお問い合わせください。

PAGE TOP

close
close
close
close
close
close